• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

药物洗脱微球经动脉化疗栓塞术与肝切除术序贯治疗大的孤立性结节型肝细胞癌后的完全缓解

Complete Remission after Sequential Therapy of Drug Eluting Beads Transarterial Chemoembolization and Liver Resection in Large Solitary Nodule Hepatocellular Carcinoma.

作者信息

Kurniawan Juferdy, Sulaiman Andri Sanityoso, Matondang Sahat Basana Romanti Ezer, Lalisang Toar Jean Maurice, Krisnuhoni Ening, Zulkifly Steven

机构信息

Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.

Department of Radiology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.

出版信息

Case Reports Hepatol. 2017;2017:3682614. doi: 10.1155/2017/3682614. Epub 2017 Sep 27.

DOI:10.1155/2017/3682614
PMID:29090102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5635291/
Abstract

Hepatocellular carcinoma (HCC) is the fifth most prevalent and the second highest cause of death among cancer. The treatment of large solitary nodule HCC is still challenging. Transarterial chemoembolization (TACE) and liver resection are two modalities of therapy in HCC management. However, recurrence rate from each therapy is relatively high. We report a case of 46-year-old man diagnosed with large solitary nodule HCC, who was treated with drug eluting bead TACE (DEB-TACE) prior to liver resection. Studies about this combination are still limited and showed various results.

摘要

肝细胞癌（HCC）是癌症中第五大常见癌症，也是第二大致死原因。大型孤立性结节型肝癌的治疗仍然具有挑战性。经动脉化疗栓塞术（TACE）和肝切除术是肝癌治疗的两种方式。然而，每种治疗方法的复发率都相对较高。我们报告了一例46岁男性，被诊断为大型孤立性结节型肝癌，在肝切除术前接受了载药微球TACE（DEB-TACE）治疗。关于这种联合治疗的研究仍然有限，且结果各异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/8222c5d963dd/CRIHEP2017-3682614.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/19f1c42b0b99/CRIHEP2017-3682614.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/9049deef54c7/CRIHEP2017-3682614.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/994e7f64a81e/CRIHEP2017-3682614.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/5081b7436877/CRIHEP2017-3682614.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/8222c5d963dd/CRIHEP2017-3682614.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/19f1c42b0b99/CRIHEP2017-3682614.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/9049deef54c7/CRIHEP2017-3682614.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/994e7f64a81e/CRIHEP2017-3682614.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/5081b7436877/CRIHEP2017-3682614.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e71a/5635291/8222c5d963dd/CRIHEP2017-3682614.005.jpg

相似文献

1
Complete Remission after Sequential Therapy of Drug Eluting Beads Transarterial Chemoembolization and Liver Resection in Large Solitary Nodule Hepatocellular Carcinoma.药物洗脱微球经动脉化疗栓塞术与肝切除术序贯治疗大的孤立性结节型肝细胞癌后的完全缓解
Case Reports Hepatol. 2017;2017:3682614. doi: 10.1155/2017/3682614. Epub 2017 Sep 27.
2
Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma.在肝细胞癌新辅助肝移植治疗中，药物洗脱微球化疗栓塞后的影像反应预测指标
World J Hepatol. 2020 Jan 27;12(1):21-33. doi: 10.4254/wjh.v12.i1.21.
3
Delayed intratumoral hemorrhage after drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma.经动脉药物洗脱微球化疗栓塞治疗肝细胞癌后延迟性瘤内出血
Case Rep Oncol. 2014 Nov 1;7(3):739-45. doi: 10.1159/000369005. eCollection 2014 Sep.
4
Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.多柔比星洗脱微球与常规经动脉化疗栓塞治疗肝细胞癌的比较。
J Gastroenterol Hepatol. 2014 May;29(5):920-5. doi: 10.1111/jgh.12439.
5
CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.载药微球与碘化油动脉化疗栓塞治疗肝细胞癌的短期疗效及安全性比较：一项短期疗效和安全性研究。
World J Surg Oncol. 2018 Mar 27;16(1):69. doi: 10.1186/s12957-018-1368-8.
6
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.传统经动脉化疗栓塞术与载药微球经动脉化疗栓塞术治疗肝细胞癌的比较
BMC Cancer. 2015 Jun 10;15:465. doi: 10.1186/s12885-015-1480-x.
7
Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma.使用40微米药物洗脱微球对肝细胞癌进行经动脉化疗栓塞术。
World J Radiol. 2017 May 28;9(5):245-252. doi: 10.4329/wjr.v9.i5.245.
8
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma.载药微球经动脉化疗栓塞术与传统经动脉化疗栓塞术治疗局部晚期肝细胞癌的比较
Hepat Med. 2016 Jun 20;8:69-74. doi: 10.2147/HMER.S105395. eCollection 2016.
9
Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.多柔比星药物洗脱微球经动脉化疗栓塞术治疗不可切除肝细胞癌时生活质量的保留：纵向前瞻性研究
J Gastroenterol Hepatol. 2015 Jul;30(7):1167-74. doi: 10.1111/jgh.12920.
10
Conventional drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma.传统药物洗脱微球经动脉化疗栓塞治疗肝细胞癌。
World J Hepatol. 2017 Jun 28;9(18):808-814. doi: 10.4254/wjh.v9.i18.808.

引用本文的文献

1
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma.微粒经导管动脉化疗栓塞联合切除术治疗巨大肝细胞癌的探索性研究
ILIVER. 2022 Mar 7;1(1):35-42. doi: 10.1016/j.iliver.2022.01.001. eCollection 2022 Mar.
2
Seizing tumor factors for mortality and survival outcomes following liver resection in Indonesia's hepatocellular carcinoma patients.探究影响印度尼西亚肝细胞癌患者肝切除术后死亡率和生存结果的肿瘤因素。
Ann Hepatobiliary Pancreat Surg. 2025 Feb 28;29(1):11-20. doi: 10.14701/ahbps.24-179. Epub 2024 Dec 30.
3
Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization.

本文引用的文献

1
Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.经动脉化疗栓塞术后肝切除可提高大/多灶性肝细胞癌患者的总生存率：一项回顾性队列研究
Oncotarget. 2017 Jan 3;8(1):408-417. doi: 10.18632/oncotarget.13427.
2
A retrospective analysis of long term outcomes in patients undergoing hepatic resection for large (>5 cm) hepatocellular carcinoma.对接受肝切除术治疗大（>5厘米）肝细胞癌患者的长期预后进行回顾性分析。
HPB (Oxford). 2016 Nov;18(11):943-949. doi: 10.1016/j.hpb.2016.08.005. Epub 2016 Sep 14.
3
Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma.
药物洗脱微球经动脉化疗栓塞术后行根治性肝切除治疗巨大肝细胞癌
Intern Med. 2019 Apr 15;58(8):1103-1110. doi: 10.2169/internalmedicine.1214-18. Epub 2019 Jan 10.
肝细胞癌药物洗脱微球化疗栓塞术（DEB-TACE）完全缓解的预测因素
Eur Radiol. 2016 Jun;26(6):1640-8. doi: 10.1007/s00330-015-3982-y. Epub 2015 Oct 11.
4
The safety and adequacy of resection on hepatocellular carcinoma larger than 10 cm: A retrospective study over 10 years.直径大于10厘米的肝细胞癌切除术的安全性与充分性：一项为期10年的回顾性研究
Ann Med Surg (Lond). 2015 May 14;4(2):193-9. doi: 10.1016/j.amsu.2015.05.003. eCollection 2015 Jun.
5
Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma.基于日本肝细胞癌临床指南的手术切除在肝细胞癌治疗中的作用
World J Hepatol. 2015 Feb 27;7(2):261-9. doi: 10.4254/wjh.v7.i2.261.
6
Transarterial chemoembolization: modalities, indication, and patient selection.经动脉化疗栓塞：方式、适应证和患者选择。
J Hepatol. 2015 May;62(5):1187-95. doi: 10.1016/j.jhep.2015.02.010. Epub 2015 Feb 12.
7
Surgical treatment for hepatocellular carcinoma.肝细胞癌的外科治疗
Saudi J Gastroenterol. 2015 Jan-Feb;21(1):11-7. doi: 10.4103/1319-3767.151216.
8
Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma.对于肝细胞癌患者而言，肿瘤大小超过5厘米后，大小就不再重要了。
World J Surg. 2014 Nov;38(11):2910-8. doi: 10.1007/s00268-014-2704-y.
9
Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis.肝细胞癌切除术后复发：模式、治疗及预后
Ann Surg. 2015 May;261(5):947-55. doi: 10.1097/SLA.0000000000000710.
10
Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.经导管动脉化疗栓塞术在肝癌手术切除前的作用。
Int J Oncol. 2013 Jan;42(1):151-60. doi: 10.3892/ijo.2012.1711. Epub 2012 Nov 21.